Allogene Therapeutics, Inc. (ALLO)
1.835
-0.02
(-0.81%)
USD |
NASDAQ |
Jun 09, 16:00
1.835
0.00 (0.00%)
After-Hours: 19:47
Allogene Therapeutics Market Cap : 449.24M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ALX Oncology Holdings, Inc. | 209.21M |
| Arrowhead Pharmaceuticals, Inc. | 10.31B |
| Oncolytics Biotech, Inc. | 94.11M |
| Sangamo Therapeutics, Inc. | 71.26M |
| Sarepta Therapeutics, Inc. | 1.679B |
Market Cap Related Metrics
| Price to Book Value | 1.611 |
| Price | 1.835 |
| Earnings Yield | -41.86% |